Patients who declined or were not eligible for thrombolysis were recruited into a (AIS w/o tPA) group, and blood samples from these patients were drawn at 3.5 ± 0.5 h and 6.5 ± 0.5 h post stroke symptom onset. The gene discussed is PLAT; the disease is Stroke.